US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class III · Low risk Terminated

Bevacizumab 2.5 mg/0.1 mL

Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.

Pine Pharmaceuticals, LLC NDC 69194-0458-1 D-0531-2023
Class III · Low risk Terminated

Montelukast Sodium Oral Granules USP

Reason Failed Impurities/Degradation Specifications: failed impurities for Sulphoxide and Impurity A.

Teva Pharmaceuticals USA Inc NDC 0093-7487-56 D-0510-2023
Class II · Moderate risk Terminated

Alprazolam Tab

Reason CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.

Preferred Pharmaceuticals, Inc. NDC 68788-7596-3 D-0506-2023
Class II · Moderate risk Terminated

Alprazolam Tab

Reason CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.

Preferred Pharmaceuticals, Inc. NDC 68788-7595-3 D-0505-2023
Class II · Moderate risk Terminated

Alprazolam Tab

Reason CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.

Preferred Pharmaceuticals, Inc. NDC 68788-7594-3 D-0504-2023
Class II · Moderate risk Ongoing

Glimepiride Tablets USP

Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Preferred Pharmaceuticals, Inc. NDC 68788-8066-9 D-0527-2023
Class II · Moderate risk Ongoing

Tadalafil Tablets

Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Preferred Pharmaceuticals, Inc. NDC 68788-8153-7 D-0526-2023
Class II · Moderate risk Ongoing

Simvastatin Tablets

Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Preferred Pharmaceuticals, Inc. NDC 68788-9868-9 D-0525-2023
Class II · Moderate risk Ongoing

Simvastatin Tablets

Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Preferred Pharmaceuticals, Inc. NDC 68788-9869-9 D-0524-2023
Class II · Moderate risk Ongoing

Simvastatin Tablets

Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Preferred Pharmaceuticals, Inc. NDC 68788-9429-9 D-0523-2023
Class II · Moderate risk Ongoing

Simvastatin Tablets

Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Preferred Pharmaceuticals, Inc. NDC 68788-9747-9 D-0522-2023
Class II · Moderate risk Ongoing

Pravastatin Sodium Tablets

Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Preferred Pharmaceuticals, Inc. NDC 68788-8215-9 D-0521-2023
Class II · Moderate risk Ongoing

Rosuvastatin Tablets

Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Preferred Pharmaceuticals, Inc. NDC 68788-7971-3 D-0520-2023
Class II · Moderate risk Ongoing

Rosuvastatin Tablets

Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Preferred Pharmaceuticals, Inc. NDC 68788-7086-3 D-0519-2023
Class II · Moderate risk Ongoing

Montelukast Sodium Tablets

Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Preferred Pharmaceuticals, Inc. NDC 68788-9438-3 D-0518-2023
Class II · Moderate risk Ongoing

Glimepiride Tablets

Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Preferred Pharmaceuticals, Inc. NDC 68788-8095-9 D-0517-2023
Class II · Moderate risk Ongoing

Finasteride Tablets

Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Preferred Pharmaceuticals, Inc. NDC 68788-6976-3 D-0516-2023
Class II · Moderate risk Ongoing

Doxazosin Tablets

Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Preferred Pharmaceuticals, Inc. NDC 68788-7149-1 D-0515-2023
Class II · Moderate risk Ongoing

Doxazosin Tablets

Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Preferred Pharmaceuticals, Inc. NDC 68788-7328-1 D-0514-2023
Class II · Moderate risk Ongoing

Clopidogrel Tablets USP

Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Preferred Pharmaceuticals, Inc. NDC 68788-8190-9 D-0513-2023
Class II · Moderate risk Ongoing

Atorvastatin Calcium Tablets

Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Preferred Pharmaceuticals, Inc. NDC 68788-7631-9 D-0512-2023
Class II · Moderate risk Ongoing

Atorvastatin Calcium Tablets

Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Preferred Pharmaceuticals, Inc. NDC 68788-7630-9 D-0511-2023
Class II · Moderate risk Ongoing

Alprazolam C-IV

Reason CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.

Direct Rx NDC 72189-121-60 D-0509-2023
Class II · Moderate risk Ongoing

Alprazolam C-IV

Reason CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.

Direct Rx NDC 72189-213-30 D-0508-2023
Class II · Moderate risk Ongoing

Alprazolam C-IV

Reason CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.

Direct Rx NDC 72189-0240-30 D-0507-2023